Circulating TNFα levels in older men and women do not show independent prospective relations with MI or stroke

Atherosclerosis

Volumn 205, Issue 1, 2009, Pages 302-308

  Jefferis, Barbara J ^a   Whincup, Peter H ^b   Welsh, Paul ^c   Wannamethee, S Goya ^a   Rumley, Ann ^c   Lennon, Lucy T ^a   Thomson, Andrew G ^a   Carson, Claire ^d   Ebrahim, Shah ^d   Lowe, Gordon D O ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cohort; Epidemiology; Inflammation; Myocardial infarction; Prospective; Stroke; TNF

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; BIOSYNTHESIS; BLOOD; COHORT ANALYSIS; INFLAMMATION; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY;

AGED; COHORT STUDIES; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349199505     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.001     Document Type: Article

References (30)

1. Packard R.R., and Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54 (2008) 24-38
2. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
3. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
4. Di N.M., Schwaninger M., Cappelli R., et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36 (2005) 1316-1329
5. Danesh J., Kaptoge S., Mann A.G., et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 5 (2008) e78
6. Kaartinen M., Penttila A., and Kovanen P.T. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 94 (1996) 2787-2792
7. Kleemann R., Zadelaar S., and Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79 (2008) 360-376
8. Popa C., Netea M.G., van Riel P.L.C.M., et al. The role of TNF-{alpha} in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 48 (2007) 751-762
9. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83 (2006) 456S-460S
10. Skoog T., Dichtl W., Boquist S., et al. Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J 23 (2002) 376-383
11. Cesari M., Penninx B.W.J.H., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC Study. Circulation 108 (2003) 2317-2322
12. Tuomisto K., Jousilahti P., Sundvall J., et al. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost 95 (2006) 511-518
13. Sukhija R., Fahdi I., Garza L., et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol 99 (2007) 879-884
14. Kilic T., Ural D., Ural E., et al. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Heart 92 (2006) 1041-1046
15. Ridker P.M., Rifai N., Pfeffer M., et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101 (2000) 2149-2153
16. Welsh P., Lowe G.D., Chalmers J., et al. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 39 (2008) 2226-2230
17. Stott D.J., Welsh P., Rumley A., et al. Adipocytokines and risk of stroke in older people: a nested case-control study. Int J Epidemiol (2008) 10.1093/ije/dyn215
18. Walker M., Whincup P.H., and Shaper A.G. The British Regional Heart Study 1975-2004. Int J Epidemiol 33 (2004) 1185-1192
19. Lawlor D.A., Bedford C., Taylor M., et al. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. J Epidemiol Community Health 57 (2003) 134-140
20. World Health Organization Expert Committee. Hypertension and coronary heart disease: classification and criteria for epidemiological studies. Geneva: World Health Organization; 1959. Report No.: 168.
21. Wannamethee S.G., Lowe G.D., Whincup P.H., et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105 (2002) 1785-1790
22. Emberson J.R., Whincup P.H., Morris R.W., et al. Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil 11 (2004) 125-134
23. Rosner B., Spiegelman D., and Willett W.C. Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol 136 (1992) 1400-1413
24. Welsh P., Woodward M., Rumley A., et al. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 141 (2008) 852-861
25. Borst S.E. The role of TNF-alpha in insulin resistance. Endocrine 23 (2004) 177-182
26. Hotamisligil G.S., Arner P., Caro J.F., et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95 (1995) 2409-2415
27. Shai I., Schulze M.B., Manson J.E., et al. A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 28 (2005) 1376-1382
28. Bennet A.M., van Maarle M.C., Hallqvist J., et al. Association of TNF-[alpha] serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 187 (2006) 408-414
29. Walker M.K., Whincup P.H., Shaper A.G., et al. Validation of patient recall of doctor-diagnosed heart attack and stroke: a postal questionnaire and record review comparison. Am J Epidemiol 148 (1998) 355-361
30. Uhlar C.M., Grehan S., Steel D.M., et al. Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: differential kinetics of SAA2 promoter induction by IL-1 beta and TNF-alpha compared to IL-6. J Immunol Methods 203 (1997) 123-130